中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 9
Sep.  2013
Turn off MathJax
Article Contents

Investigation of artificial liver support system combined with stem cell transplantation in treatment of liver failure

DOI: 10.3969/j.issn.1001-5256.2013.09.009
Research funding:

 

  • Received Date: 2013-06-26
  • Published Date: 2013-09-20
  • Currently, the main treatment strategies for liver failure include comprehensive medical treatment, artificial liver support system treatment, liver transplantation, and stem cell transplantation. In recent years, major progress has been made in liver failure treatment with artificial liver support system and stem cell transplantation. Non- bioartificial liver treatments commonly seen in the clinical setting, as well as the cell source, cell culture method, bioreactor, and clinical application of bioartificial liver, are reviewed. The mechanism and clinical application of stem cell therapy for liver failure are discussed. In view of the unsatisfactory clinical effect of artificial liver or stem cells alone in the treatment of liver failure, the feasibility of combination therapy with artificial liver and stem cells for liver failure is proposed.

     

  • loading
  • [1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association;Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association.Diagnostic and treatment guidelines for liver failure[J].Chin J Clin Infect Dis, 2012, 5 (6) :321-327. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南[J].中华临床感染病杂志, 2012, 5 (6) :321-327.
    [2]YE YN, GAO ZL.Three attacks in the development of HBV-related liver failure[J].Infect Dis Info, 2009, 22 (5) :276-279. (in Chinese) 叶一农, 高志良.乙型肝炎肝衰竭发生机制中的三重打击[J].传染病信息, 2009, 22 (5) :276-279.
    [3] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.Non biological artificial liver support system treatment guidelines for liver failure[J].Chin J Clin Infect Dis, 2009, 2 (6) :321-325. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组.非生物型人工肝支持系统治疗肝衰竭指南[J].中华临床感染病杂志, 2009, 2 (6) :321-325.
    [4]LI LJ, LIU XL, XU XW, et al.Comparison of plasma exchange with different membrane pore sizes in the treatment of severe viral hepatitis[J].Ther Apher Dial, 2005, 9 (5) :396-401.
    [5]HASSANEIN T, BLEI AT, PERRY W, et al.Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy[J].Am J Gastroenterol, 2009, 104 (6) :1392-1400.
    [6]BANARES R, NEVENS F, LARSEN FS, et al.Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure:the RELIEF trial[J].Hepatology, 2013, 57 (3) :1153-1162.
    [7]KRIBBEN A, GERKEN G, HAAG S, et al.Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure[J].Gastroenterology, 2012, 142 (4) :782-789.
    [8] LEE KD, KUO TK, WHANG-PENG J, et al.In vitro hepatic differentiation of human mesenchymal stem cells[J].Hepatology, 2004, 40 (6) :1275-1284.
    [9]BANAS A, TERATANI T, YAMAMOTO Y, et al.Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes[J].Hepatology, 2007, 46 (1) :219-228.
    [10] AURICH I, MUELLER LP, AURICH H, et al.Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers[J].Gut, 2007, 56 (3) :405-415.
    [11]GERLACH JC, MUTIG K, SAUER IM, et al.Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors:a morphologic study[J].Transplantation, 2003, 76 (5) :781-786.
    [12]LECKIE P, DAVENPORT A, JALAN R.Extracorporeal liver support[J].Blood Purif, 2012, 34 (2) :158-163.
    [13]PODOLL AS, de GOLOVINE A, FINKEL KW.Liver support systems-a review[J].ASAIO J, 2012, 58 (5) :443-449.
    [14]DOMINICI M, Le BLANC K, MUELLER I, et al.Minimal criteria for defining multipotent mesenchymal stromal cells.The International Society for Cellular Therapy position statement[J].Cytotherapy, 2006, 8 (4) :315-317.
    [15]ARIKURA J, INAGAKI M, HUILING X, et al.Colonization of albumin-producing hepatocytes derived from transplanted F344 rat bone marrow cells in the liver of congenic Nagase's analbuminemic rats[J].J Hepatol, 2004, 41 (2) :215-221.
    [16]JU S, TENG GJ, LU H, et al.In vivo differentiation of magnetically labeled mesenchymal stem cells into hepatocytes for cell therapy to repair damaged liver[J].Invest Radiol, 2010, 45 (10) :625-633.
    [17] De MIGUEL MP, FUENTES-JULIN S, BLZQUEZ-MARTNEZ A, et al.Immunosuppressive properties of mesenchymal stem cells:advances and applications[J].Curr Mol Med, 2012, 12 (5) :574-591.
    [18]DAI LJ, LI HY, GUAN LX, et al.The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis[J].Stem Cell Res, 2009, 2 (1) :16-25.
    [19] PENG L, XIE DY, LIN BL, et al.Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B:short-term and long-term outcomes[J].Hepatology, 2011, 54 (3) :820-828.
    [20]PENG L, LI H, GU L, et al.Comparison of biological characteristics of marrow mesenchymal stem cells in hepatitis B patients and normal adults[J].World J Gastroenterol, 2007, 13 (11) :1743-1746.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (3155) PDF downloads(742) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return